We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Leo Bear-McGuinness

Science Writer

Contact Us

@LeoMcBear

Leo joined Analytical Cannabis in 2019. From research to regulations and analysis to agriculture, his writing covers all the need-to-know news for the cannabis industry. He holds a bachelor's degree in biology from Newcastle University and a master's degree in science communication from the University of Edinburgh.

Latest Content From Leo Bear-McGuinness

FDA Submits New CBD Policies to White House for Review

If given approval, the new regulations could come into effect in a matter of weeks.

VIEW

Hemp Pet Products Recalled Due to High Lead Levels, FDA Announces

A US company is voluntarily recalling a swathe of hemp tincture products, intended for dog, cat, and human consumption, after the Florida Department of Health tested some samples and found dangerous levels of lead.

VIEW

Nebraska Approves its First Hemp Testing Lab

Cannabis Testing Laboratories, which received ISO-certification in early July, was later added to Nebraska’s Department of Agriculture’s list of approved hemp testing facilities.

VIEW

Why Do Some Hemp Crops Produce Too Much THC? This New Study Aims to Find Out

Which factors are tipping these THC concentrations over the legal limit? The soil? The sun? The strain? Right now, it’s not entirely clear. But one research group at West Virginia University want to change that.

VIEW

Rhode Island Licenses its First Medical Cannabis Lab

Up until Green Peaks’ approval, any medical cannabis sold in Rhode Island dispensaries had either been tested by growers, by the dispensaries, or by unlicensed, private labs.

VIEW

European Commission Considers Reclassifying CBD as a Narcotic

The review has paused over 50 applications from CBD companies hoping to acquire a “novel food” status for their products.

VIEW

Cannabis Could be a Promising Treatment for Sickle Cell Disease, Clinical Trial Concludes

The disease's painful symptoms are often treated with prescription opioids. But a new clinical trial has found that cannabis could be a promising, and safer, substitute.

VIEW

US Cannabis Sales Stay Steady

Sales of cannabis have continued to stay at pre-pandemic levels in the US, according to the cannabis market research firm BDSA.

VIEW

Colorado Further Adds to Its List of Acceptable Cannabis Pesticides

The Colorado Department of Agriculture has once again expanded its list of pesticides approved for use on cannabis crops.

VIEW

New Zealand’s Cannabis Legalization Bill Could Do With Some Improvements, Say Addiction Researchers

Before the 'reefer-endum' arrives, the country's legalization bill could still benefit from a few edits, say leading addiction researchers.

VIEW